ML318
CAS: 1610516-67-0
Ref. 3D-KPC51667
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Informação sobre produto
ML318 is an analog inhibitor that has shown promising results in the treatment of cancer. It has been found to induce apoptosis in human cancer cells, which makes it a potential candidate for anticancer therapy. ML318 acts as a kinase inhibitor, which means it prevents the activity of enzymes that are involved in cell growth and division. This drug has been tested on various types of tumors, including those found in breast, lung, and prostate cancers. Studies have also shown that ML318 can act as an oxytocin receptor antagonist, which could potentially have therapeutic applications for conditions such as preterm labor or postpartum hemorrhage. Despite its potential benefits, ML318 should be used with caution due to its caffeine-like effects and interactions with other medications.
Propriedades químicas
Consulta técnica sobre: 3D-KPC51667 ML318
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
